Esteve invests €100 million in new manufacturing plant in Spain
Esteve team. Source: [1]
Spain-headquartered CMO Esteve expands its manufacutring capacity in plants in Girona, Spain to increase global API offerings with advanced technological solutions, through a weighty investment of €100 million.
Esteve is a leading healthcare company and pharmaceutical innovator and partner based in Spain.
Esteve has a global presence, mostly throughout Europe, but with industrial sites in China and Mexico. In Spain, Esteve has a chemical R&D centre in Barcelona, and three production plants in the Catalan region, located in Celrà (Gironès), Banyeres del Penedès (Baix Penedès), and Lliçà de Vall (Vallès Oriental). Now, they have plans to further increase manufacturing capacity in the region.
Esteve has initiated a project to construct a new manufacturing unit at its Celrà plant in Girona, with plans to invest €100 million through to 2026. The expansion aims to boost the production capacity of active pharmaceutical ingredients at its primary industrial site. Once the new facilities become operational in the latter quarter of 2026, the company will welcome approximately 100 new employees to its existing team of 370 professionals. The expansion includes building new production and service facilities and installing up to 150 m3 of reaction volume, leading to a 45% increase in Esteve's production capacity at Celrà and a 15% increase in the overall global capacity of the company.
The new unit in Girona illustrates the dedication to advancements in developing, manufacturing, and sales of APIs for CMOs. The latest technological solutions, including in digitalisation and data analysis, incorporated into the facility will ensure the efficient production of highly-potent APIs.
The facility enables the production of new products to be added to Esteve’s portfolio, which will be distributed throughout the USA, Europe, and Japan.
"Thanks to our commitment to quality, efficiency and reliability, our activity in the development and manufacturing of active pharmaceutical ingredients has experienced notable growth in recent years. The expansion of our main industrial centre will allow us to satisfy a growing global demand and expand our activity, advancing our mission of improving people's lives", commented Pere Mañé, the General Manager of Esteve Química.
Source:
[1] Esteve Química. Esteve will invest 100 million euros in the construction of a new plant at its industrial centre in Celrà (Girona). [Date accessed 09/07/2024] www.esteve.com/global/news/esteve-will-invest-100-million-euros-in-the-construction-of-a-new-plant-at-its-industrial-centre-in-celra-girona
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: Bridging Science, Strategy, and Equity in Chemicals and Pharma
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News CPHI Podcast Series: Pharmapack special – Delivering innovation for patient outcomes
This special Pharmapack episode of our podcast, recorded live at Pharmapack 2026, interviews Terence O’Hagan, Vice President of Business Development for Drug Delivery Systems at Stevanato Group, sharing exclusive insights into the company’s... -
News Where Pharma Innovation Takes the Spotlight: Pharmapack Awards 2026
The 2026 Pharmapack Awards, held January 21, 2026, celebrated and recognised leading companies in the pharmaceutical packaging sector paving the way for packaging and drug delivery excellence in the future.
-
News Pharmapack 2026 - From the Floor
Celebrating its 25th anniversary in the city where it all started, Pharmapack 2026 is back in Paris! From January 21-22, 2026, Paris Expo Porte de Versailles opens its doors again to the pharmaceutical packaging and drug delivery sectors, ready for 2 d... -
News Driving Sustainability with Citeo PRO: An Exclusive Interview
Citeo PRO is transforming professional packaging with innovative solutions, collective action, and a dedication to sustainability within the pharmaceutical sector. Discover how they are supporting companies at Pharmapack 2026 in this interview with Dom... -
News Pharmapack's Silver Jubilee: Celebrating 25 Years of Packaging Innovation
For 25 years, Pharmapack has been at the forefront of innovation, collaboration, and progress in the pharmaceutical packaging and drug delivery industry. From its humble beginnings to becoming a global hub for industry leaders, the event has witnessed ... -
News Shaping the future of self-injection: Ypsomed's innovations at Pharmapack's 25th anniversary
Pharmapack 2026 marks a significant milestone as it celebrates its 25th anniversary, bringing together global leaders in pharmaceutical packaging and drug delivery. In this exclusive interview, Ypsomed, a pioneering developer and manufacturer of subcut...